FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christian Schindlbeck

Research Profile

Disorders

Anatomy

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Christian Schindlbeck; Harald Sommer; Ulrich Andergassen; Klaus Friese; Simone Hofmann; Wolfgang Janni; Udo Jeschke; Julia Jückstock; Brigitte Rack
Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.
Ulrich Andergassen; Klaus Friese; Sabine Heublein; Stefan Hutter; Matthias Ilmer; Alexandra C Kölbl; Brigitte Rack; Christian Schindlbeck; Michael Zebisch; Udo Jeschke
Detection of breast cancer cells in blood samples by immunostaining of the Thomsen-Friedenreich antigen.
Ulrich Andergassen; Verena Engelstädter; Klaus Friese; Simone Hofmann; Stefan Hutter; Matthias Ilmer; Alexandra C Kölbl; Julia Neugebauer; Christian Schindlbeck; Udo Jeschke
Detection of Tumor Cell-Specific mRNA in the Peripheral Blood of Patients with Breast Cancer—Evaluation of Several Markers with Real-Time Reverse Transcription-PCR.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christian Schindlbeck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Christian Schindlbeck; Harald Sommer; Ulrich Andergassen; Klaus Friese; Simone Hofmann; Wolfgang Janni; Udo Jeschke; Julia Jückstock; Brigitte Rack
Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.
Journal of cancer research and clinical oncology 2013;139(6):1055-62.
2013: Ulrich Andergassen; Klaus Friese; Sabine Heublein; Stefan Hutter; Matthias Ilmer; Alexandra C Kölbl; Brigitte Rack; Christian Schindlbeck; Michael Zebisch; Udo Jeschke
Detection of breast cancer cells in blood samples by immunostaining of the Thomsen-Friedenreich antigen.
Future oncology (London, England) 2013;9(5):747-52.
2013: Ulrich Andergassen; Verena Engelstädter; Klaus Friese; Simone Hofmann; Stefan Hutter; Matthias Ilmer; Alexandra C Kölbl; Julia Neugebauer; Christian Schindlbeck; Udo Jeschke
Detection of Tumor Cell-Specific mRNA in the Peripheral Blood of Patients with Breast Cancer—Evaluation of Several Markers with Real-Time Reverse Transcription-PCR.
International journal of molecular sciences 2013;14(1):1093-104.
2012: Michael Zebisch; Klaus Friese; Sabine Heublein; Matthias Ilmer; Udo Jeschke; Alexandra C Kölbl; Julia Neugebauer; Brigitte Rack; Christian Schindlbeck; Ulrich Andergassen
Quantification of breast cancer cells in peripheral blood samples by real-time rt-PCR.
Anticancer research 2012;32(12):5387-91.
2012: Darius Dian; Klaus Friese; Christina Kuhn; Antonis Makrigiannakis; Ioannis Mylonas; Iordanis Navrozoglou; Christian Schindlbeck; Naim Shabani; Thomas Vrekoussis; Udo Jeschke
Expression of cathepsin-D in primary breast cancer and corresponding local recurrence or metastasis: an immunohistochemical study.
Anticancer research 2012;32(3):901-5.
2011: Christian Schindlbeck; H Sommer; U Andergassen; Klaus Friese; Wolfgang Janni; J Jueckstock; G Pfab; Brigitte Rack
Prognostic relevance of disseminated tumor cells in the bone marrow of patients with primary breast cancer--results of a standardized follow-up.
Anticancer research 2011;31(9):2749-55.
2010: N Burkhardt; J Jückstock; Christina Kuhn; Brigitte Rack; Wolfgang Janni; Christian Schindlbeck; Harald Sommer; Klaus Friese; Ioannis Mylonas
Inhibin A is down-regulated during chemotherapy in patients with breast cancer.
Anticancer research 2010;30(11):4563-6.
2010: Tanja Fehm; Volkmar Müller; Bahriye Aktas; Wolfgang Janni; Andreas Schneeweiss; Elmar Stickeler; Claus Lattrich; Christian R Löhberg; Erich Solomayer; Brigitte Rack; Sabine Riethdorf; Christoph Klein; Christian Schindlbeck; Kerstin Brocker; Sabine Kasimir-Bauer; Diethelm Wallwiener; Klaus Pantel
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.
Breast cancer research and treatment 2010;124(2):403-12.
2010: Tobias M Weissenbacher; Madeleine Zschage; Wolfgang Janni; Udo Jeschke; Thomas Dimpfl; Doris Mayr; Brigitte Rack; Christian Schindlbeck; Klaus Friese; Darius Dian
Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
Breast cancer research and treatment 2010;122(1):27-34.
2010: Christian Schindlbeck; Doris Mayr; C Olivier; Brigitte Rack; V Engelstaedter; J Jueckstock; C Jenderek; U Andergassen; Udo Jeschke; Klaus Friese
Topoisomerase IIalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer.
Journal of cancer research and clinical oncology 2010;136(7):1029-37.
2010: Brigitte Rack; Christian Schindlbeck; Julia Jückstock; Eva-Maria Genss; Philip Hepp; Ralf Lorenz; Hans Tesch; Andreas Schneeweiss; Matthias W Beckmann; Werner Lichtenegger; Harald Sommer; Klaus Friese; Wolfgang Janni
Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.
Anticancer research 2010;30(5):1837-41.
2010: Brigitte Rack; Julia Jückstock; Eva-Maria Genss; Alexandra Schoberth; Christian Schindlbeck; Barbara Strobl; Maja Heinrigs; Gerhard Rammel; Thomas Zwingers; Harald Sommer; Klaus Friese; Wolfgang Janni
Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
Anticancer research 2010;30(5):1807-13.
2009: Alexander Karl; Stefan Tritschler; S Hofmann; Christian G Stief; Christian Schindlbeck
Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer.
European journal of medical research 2009;14(11):487-90.
2009: Ioannis Mylonas; Silvia Worbs; Naim Shabani; Christina Kuhn; Susanne Kunze; Sandra Schulze; Darius Dian; Andrea Gingelmaier; Christian Schindlbeck; Ansgar Brüning; Harald Sommer; Udo Jeschke; Klaus Friese
Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases.
European journal of cancer (Oxford, England : 1990) 2009;45(7):1304-14.
2008: Christian Schindlbeck; Konstanze Klauser; Darius Dian; Wolfgang Janni; Klaus Friese
Comparison of total laparoscopic, vaginal and abdominal hysterectomy.
Archives of gynecology and obstetrics 2008;277(4):331-7.
2008: Brigitte Rack; Christian Schindlbeck; Barbara Strobl; Harald Sommer; Klaus Friese; Wolfgang Janni
[Efficacy of zoledronate in treating persisting isolated tumor cells in bone marrow in patients with breast cancer. A phase II pilot study].
Deutsche medizinische Wochenschrift (1946) 2008;133(7):285-9.
2008: Brigitte Rack; Volker Heinemann; Christian Schindlbeck; J Walther; Christoph Salat; H Sommer
[Metastatic breast cancer--new methods of treatment].
MMW Fortschritte der Medizin 2008;150(1-2):34-6.
2008: Christian Schindlbeck; Julia Stellwagen; Udo Jeschke; Uwe Karsten; Brigitte Rack; Wolfgang Janni; Julia Jückstock; Augustinos Tulusan; Harald Sommer; Klaus Friese
Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Clinical & experimental metastasis 2008;25(3):233-40.
2007: Naim Shabani; Christina Kuhn; Susanne Kunze; Sandra Schulze; Doris Mayr; Darius Dian; Andrea Gingelmaier; Christian Schindlbeck; Franz Willgeroth; Harald Sommer; Udo Jeschke; Klaus Friese; Ioannis Mylonas
Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas.
European journal of cancer (Oxford, England : 1990) 2007;43(16):2434-44.
2007: Christian Schindlbeck; Peer Hantschmann; M Zerzer; B Jahns; Dorothea Rjosk; Wolfgang Janni; Brigitte Rack; Harald Sommer; Klaus Friese
Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(5):1047-55.
2007: Udo Jeschke; Ioannis Mylonas; Christina Kuhn; Naim Shabani; Christiane Kunert-Keil; Christian Schindlbeck; Bernd Gerber; Klaus Friese
Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Anticancer research 2007;27(4A):1969-74.
2007: Sabine Riethdorf; Herbert Fritsche; Volkmar Müller; Thomas Rau; Christian Schindlbeck; Brigitte Rack; Wolfgang Janni; Cornelia Coith; Katrin Beck; Fritz Jänicke; Summer Jackson; Terrie Gornet; Massimo Cristofanilli; Klaus Pantel
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(3):920-8.
2007: Christian Schindlbeck; Udo Jeschke; Sandra Schulze; Uwe Karsten; Wolfgang Janni; Brigitte Rack; Stan Krajewski; Harald Sommer; Klaus Friese
Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Breast cancer research and treatment 2007;101(1):17-25.
2006: Tanja Fehm; Stephan Braun; Volkmar Muller; Wolfgang Janni; Gerhard Gebauer; Christian Marth; Christian Schindlbeck; Diethelm Wallwiener; Elin Borgen; Bjørn Naume; Klaus Pantel; Erich Solomayer
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.
Cancer 2006;107(5):885-92.
2006: Christian Schindlbeck; Wolfgang Janni; Klaus Friese
Failure of Implanon contraception in a patient taking carbamazepin for epilepsia.
Archives of gynecology and obstetrics 2006;273(4):255-6.
2005: Christian Schindlbeck; Wolfgang Janni; Naim Shabani; A Kornmeier; Brigitte Rack; Dorothea Rjosk; Bernd Gerber; Stephan Braun; Harald Sommer; Klaus Friese
Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIalpha-status of the primary tumor?
Journal of cancer research and clinical oncology 2005;131(8):539-46.
2005: Christian Schindlbeck; Udo Jeschke; Sandra Schulze; Uwe Karsten; Wolfgang Janni; Brigitte Rack; Harald Sommer; Klaus Friese
Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
Histochemistry and cell biology 2005;123(6):631-7.
2005: Udo Jeschke; Ioannis Mylonas; Naim Shabani; Christiane Kunert-Keil; Christian Schindlbeck; Bernd Gerber; Klaus Friese
Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Anticancer research 2005;25(3A):1615-22.
2005: Wolfgang Janni; Brigitte Rack; Christian Schindlbeck; Barbara Strobl; Dorothea Rjosk; Stephan Braun; Harald Sommer; Klaus Pantel; Bernd Gerber; Klaus Friese
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
Cancer 2005;103(5):884-91.
2005: Christian Schindlbeck; Theresa Kampik; Wolfgang Janni; Brigitte Rack; Udo Jeschke; Stan Krajewski; Harald Sommer; Klaus Friese
Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
Breast cancer research : BCR 2005;7(6):R1174-85.
2004: Christian Schindlbeck; Wolfgang Janni; Naim Shabani; Brigitte Rack; Bernd Gerber; Manfred Schmitt; Nadia Harbeck; Harald Sommer; Stephan Braun; Klaus Friese
Comparative analysis between the HER2 status in primary breast cancer tissue and the detection of isolated tumor cells in the bone marrow.
Breast cancer research and treatment 2004;87(1):65-74.
2003: Brigitte Rack; Wolfgang Janni; Bernd Gerber; Barbara Strobl; Christian Schindlbeck; Elisabeth Klanner; Gerhard Rammel; Harald Sommer; Thomas Dimpfl; Klaus Friese
Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Breast cancer research and treatment 2003;82(2):83-92.
2003: Wolfgang Janni; Florian Hepp; Barbara Strobl; Brigitte Rack; Dorothea Rjosk; Christina Kentenich; Christian Schindlbeck; Peer Hantschmann; Klaus Pantel; Harald Sommer; Stephan Braun
Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
Cancer 2003;97(2):405-11.
2002: Wolfgang Janni; Barbara Strobl; Brigitte Rack; Dorothea Rjosk; Christian Schindlbeck; Peer Hantschmann; Christina Kentenich; W Sigg; M Zerzer; Harald Sommer
[The influence of the hemoglobin concentration on the hematogenous tumor cell dissemination at the time of the initial diagnosis of breast cancer].
Deutsche medizinische Wochenschrift (1946) 2002;127(3):71-7.
2002: Brigitte Rack; Wolfgang Janni; Christina Kentenich; Barbara Strobl; Elisabeth Klanner; Christian Schindlbeck; Florian Hepp; Harald Sommer; Stephan Braun
[Incidence and prognostic significance of disseminated tumor cells in patients with cervical cancer].
Acta medica Austriaca. Supplement 2002;59():36-41.
2002: Christian Schindlbeck; Wolfgang Janni; P Schaffer; Naim Shabani; Manfred Schmitt; Nadia Harbeck; Harald Sommer; Stephan Braun
[Tumor biology of primary breast cancer and minimal residual disease].
Acta medica Austriaca. Supplement 2002;59():27-31.
2001: Wolfgang Janni; Florian Hepp; Dorothea Rjosk; Christina Kentenich; Barbara Strobl; Christian Schindlbeck; Peer Hantschmann; Harald Sommer; Klaus Pantel; Stephan Braun
The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence.
Cancer 2001;92(1):46-53.
2001: Stephan Braun; B S Cevatli; C Assemi; Wolfgang Janni; Christina Kentenich; Christian Schindlbeck; Dorothea Rjosk; Florian Hepp
Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(5):1468-75.
2001: Stephan Braun; Christian Schindlbeck; Florian Hepp; Wolfgang Janni; Christina Kentenich; Gert Riethmüller; Klaus Pantel
Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):368-75.
2001: Wolfgang Janni; Dorothea Rjosk; Barbara Strobl; Florian Bergauer; F Linka; Thomas Dimpfl; Christian Schindlbeck; Brigitte Rack; Ralph Kaestner; Harald Sommer
[Chemotherapy-associated myelosuppression in gynecological oncology].
Gynäkologisch-geburtshilfliche Rundschau 2001;41(3):166-73.
2000: Wolfgang Janni; S Gastroph; Florian Hepp; Christina Kentenich; Dorothea Rjosk; Christian Schindlbeck; Thomas Dimpfl; Harald Sommer; Stephan Braun
Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.
Cancer 2000;88(10):2252-9.